| Tag | Content |
|---|
EnhancerAtlas ID | HS018-05382 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr12:68767490-68769540 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXP2 | MA0593.1 | chr12:68767958-68767969 | AAGTAAACAAA | + | 6.62 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09841 | chr12:68766512-68769042 | CD14 | | SE_39838 | chr12:68767459-68768017 | Jurkat | | SE_44133 | chr12:68766394-68769946 | MM1S | | SE_49866 | chr12:68767450-68777807 | RPMI-8402 | | SE_66689 | chr12:68767459-68768017 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I068373 | chr12 | 68767381 | 68769061 |
|
Enhancer Sequence | GGTGTGAGCC ACCACGCCCG GCGGACTGTG GGTAGTTTTT CTACCTTCAT ATTTTCTAGC 60
ATTTCCAAAC TTTGTTTAAT GACCATGTGT TATTTTCATA ATGGGAAAAA AAAAACATGG 120
TTTAAGGAAG ATGAGCCTTA TAGTGTTCTG CCTGAAAGTC CCTCAGAGCC TTTGGGACTT 180
GCTAAGCCAG AGGCCTCTGT GTCTGTACAA GAACTCACAC CCACGTGCTG ACCTATAATG 240
TCCCAGGTTC TGCCCACAGT CTACACTGAG AGGGTGTAAT TTTCCATAGG CCAGGGACTC 300
AAGTAAAAGC AGAAGTTGGC AGATGTAACA GCAACTGAGT GGGAAGAGAG AAGAGAGATG 360
GCCTCCAACT CATACATAAA ATCCAAGCGT TCATTCATTC ATTTATCTAT TCACCAATAT 420
TAAGCACCCA CTGTGTAGGA GGCACTGTTC TAGGCGCTGC AGATACAGAA GTAAACAAAA 480
TGACAAAGTC CTAGTTACAC ATTCTAGGAA ATAAGATAGA CCATCTATGA ATTAAGATTC 540
AGCTAACTGT ACTCCCTCCC TCATTTGAAG AAGTAGAGCC GCATGCCATA CTGCTATTTA 600
CTGACAAGAG TGGTTTAGGA AACTTTGCGA AGTAATTACA GGTTTGATGA CTCATAGCCA 660
TACTAAATGT GGCACCTGTA AACAGATACC TATGCGTGCC ATGGTGTTTG TGACTGGGTT 720
GGCTGGGTTG GGTATCACTG TTTCTAGAAC AGGGCTTTCA GTATCGATTT CATATGTACC 780
TATGTACACT TACAAATGTA ACTCAAACTT CGCCTGATCT GGCCAGCCAG TGAGTACAAA 840
TGAGCTTACG CTAAAATAAC AGCACACATT TCAGTAATGT GTTCTGCCAA CCACATAAAT 900
GGAGACCTTT GCAATCTTTT CTCCCATGCT TGTATTTGGG AGCATCCAAG GGCATCTCGT 960
GTGTTCACAA ACACGCTTCT TATTTATGTT CTAGCAACCC AGCTACAGAA ATAGCCATTT 1020
GGAGCAGCTT CTCAGCCCAG CCCTTCGTAG GCATTCTGTT TTCTTGCCCA GGAAGCGGTT 1080
TAAGAAATCC CCCAAACTAC AGCTCTGGGG ACAGAAAAAC TCTCTTCTGT GGAGAAAGTA 1140
TCCCTTTCCC CTAACACTGT GGAAAGACCG AGCTGAGCCA GTTCAGGTCA AGTGTTAGGA 1200
CTCTGTAAGC ACTAGCTCTA GAAGCAACTA ACAATGTCTG GGTTTACCCT GAGCAATGTT 1260
GCTTGTGAAT CTTTGTCTCA GGGAGTTTCT TGTAAAAATC AGCACCTTCA GCTTCCGCCT 1320
GCAGACCCCT CTCTGCTGAG CACAAACCTA GTCCACAGGC TGGTCTGGGG AGCAGCCTCA 1380
TGGTGCCTTC TCCACATTCT CAGCTCCAAG CCCCAGGCAC AAATCTCCCC TCGGGTCACC 1440
AGACAGGCCT GGGCATGGCT AAATCTCAAT TAAAGGCAAA CAGGATGCGG AAAAATCAGT 1500
TTTAAAAAGA TCAGGCAAGG TTTAGGAGAA TATGAGGGCA GAAAAATCCA TCCCATACCA 1560
CTGAGAAAGG AGGAATTTAC AGAGAAGAGA GCAGGCTGGA AACAGCATTA AGCCACTCAG 1620
GACACAGTGA ATCAGAATGC AAATGGACCG ACCCAAATAG GTACCTCCTC CCCATGCTGC 1680
TGGGTCCACT CTGTCTCACA CATAACCCTC TGTCTTAGAA CTGCTATAGA GGACAGAAGG 1740
CCTCAGAGAA CCAGGAATGG AAGACAGAAG AGAGATTGCC AGGAACCATT TCTAAATTTT 1800
AATTCTGTAA GTTATAATCC AAGTTTTCTT TGATAGCAAG TTTTCCCCTG GAGAGACAGG 1860
TTAAGGGACC TTTCAGATGA CACCTTCTGT CCCTTTCTCA GCGCTAGAAG GTCAGTTCAG 1920
GAACCTACTG TTAGTTCCAA TGCCCTTGAT TGAAGTTAGC AATTTACAGA AATAGACTCA 1980
AATCCCCCTT CAAGCTGGAG ATCCTGGAGA GAATGCCCAG AGACAGAATG GGCCATCTCC 2040
AAGGCCAACT 2050
|
